Radovan Jurić

Dr. Radovan Jurić


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MKMarko Kantar
Marko Kantar
IKIvan Kuhajda
Ivan Kuhajda
Bojan JoksimovićBojan Joksimović
Bojan Joksimović
Radovan JurićRadovan Jurić
Radovan Jurić
NLNemanja R. Lazendić
Nemanja R. Lazendić
Danijela RadulovicDanijela Radulovic
Danijela Radulovic
Background/Objectives: Bilateral thoracoscopic sympathectomy (BTS) is the definitive treatment for primary focal hyperhidrosis, yet postoperative pain remains an undertreated consequence with no established analgesic consensus. This study compared three analgesic regimens on pain trajectory, opioid consumption, and functional recovery following BTS. Methods: In this prospective observational cohort study, 300 patients undergoing BTS were allocated in a non-randomized manner reflecting institutional practice to three parallel cohorts (n = 100 each): Group 1 received systemic opioids alone; Group 2 received opioids plus pre-emptive local anesthetic wound infiltration; and Group 3 received opioids plus thoracoscopic-guided intercostal nerve block (ICNB). Primary outcomes included pain intensity on the Numerical Rating Scale and total opioid consumption. Results: ICNB patients reported significantly lower mean peak pain scores (3.8 ± 1.7) versus local infiltration (4.6 ± 1.9) and opioid-only groups (5.2 ± 2.1; p < 0.001). Total opioid consumption was reduced by 38% in the ICNB group (12.4 ± 4.8 mg vs. 20.1 ± 6.3 mg; p < 0.001). Moderate-to-severe pain occurred in 42.0% of ICNB patients versus 74.0% of controls (p < 0.001). ICNB was independently associated with reduced moderate-to-severe pain (adjusted odds ratio (AOR) 0.31; 95% confidence interval (CI) 0.17–0.56; p < 0.001). ICNB patients returned to normal activities faster (median 3 vs. 5 days; p = 0.008) with higher satisfaction (91.0% vs. 78.0%; p = 0.044). Conclusions: In this observational cohort, ICNB was associated with significantly lower postoperative pain scores, reduced opioid consumption, and faster functional recovery following BTS. These findings suggest that ICNB may be an effective adjunct analgesic strategy for ambulatory BTS, pending confirmation in randomized controlled trials.

1 January 2025 in Respiratio
Verified
Journal Article
Open access
PDF file
VSVelibor Simetić
Velibor Simetić
MSMirko Stanetić
Mirko Stanetić
MKMarko Kantar
Marko Kantar
Radovan JurićRadovan Jurić
Radovan Jurić
BSBranko Strbac
Branko Strbac
MSMiroslav Stranatić
Miroslav Stranatić
Introduction: Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC), particularly adenocarcinoma, being the most common histological type in early-stage disease. Surgical resection, especially lobectomy, remains the gold standard. Since 2015, tumor spread through air spaces (STAS) has been recognized as an independent prognostic factor, gaining increasing clinical relevance.Objective: To analyze the presence of STAS in resected NSCLC patients, its association with clinicopathological features and treatment outcomes, and its impact on the choice of surgical resection extent.Materials and Methods: This retrospective study included 173 patients who underwent surgical resection for lung cancer at the Clinic for Thoracic Surgery, University Clinical Center of Republika Srpska, during the period 2023-2024. Demographic data, histopathological features, TNM staging, STAS status, recurrence, and survival outcomes were analyzed.Results: STAS was identified in 45.1% of patients, most commonly in T2 and T3 stages. Its presence was significantly associated with a higher recurrence rate and poorer prognosis. Adenocarcinoma was the predominant histological type (46.2%). Segmentectomy in STAS-positive patients was associated with inferior outcomes compared to lobectomy.Conclusion: STAS is an important prognostic factor that influences therapeutic decision-making, particularly regarding the extent of resection in early-stage NSCLC. Routine assessment and reporting of STAS status is essential to guide clinicians in choosing appropriate surgical strategies and improving long-term treatment outcomes.